Published in PLoS One on November 10, 2015
Low-Grade Inflammation, Oxidative Stress and Risk of Invasive Post-Menopausal Breast Cancer - A Nested Case-Control Study from the Malmö Diet and Cancer Cohort. PLoS One (2016) 0.77
Pretreatment TG/HDL-C Ratio Is Superior to Triacylglycerol Level as an Independent Prognostic Factor for the Survival of Triple Negative Breast Cancer Patients. J Cancer (2016) 0.75
Circulating gamma-glutamyl transferase and development of specific breast cancer subtypes: findings from the Apolipoprotein Mortality Risk (AMORIS) cohort. Breast Cancer Res (2017) 0.75
ApoA-I mimetic administration, but not increased apoA-I-containing HDL, inhibits tumour growth in a mouse model of inherited breast cancer. Sci Rep (2016) 0.75
Quantifying the genetic correlation between multiple cancer types. Cancer Epidemiol Biomarkers Prev (2017) 0.75
Detection of Lipid and Amphiphilic Biomarkers for Disease Diagnostics. Biosensors (Basel) (2017) 0.75
Measuring inconsistency in meta-analyses. BMJ (2003) 128.20
Bias in meta-analysis detected by a simple, graphical test. BMJ (1997) 122.24
Operating characteristics of a rank correlation test for publication bias. Biometrics (1994) 47.97
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol (2010) 16.24
Quantitative synthesis in systematic reviews. Ann Intern Med (1997) 11.72
Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol (1992) 8.82
Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk (1996) 6.18
Endogenous hormones and breast cancer risk. Epidemiol Rev (1993) 3.27
Serum lipids, lipid-lowering drugs, and the risk of breast cancer. Arch Intern Med (2005) 2.66
Facilitating meta-analyses by deriving relative effect and precision estimates for alternative comparisons from a set of estimates presented by exposure level or disease category. Stat Med (2008) 2.26
Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. J Natl Cancer Inst (2004) 1.93
Risk factors for malignant diseases: a cohort study on a population of 22,946 Icelanders. Cancer Epidemiol Biomarkers Prev (1997) 1.80
Endogenous hormone levels and risk of breast, endometrial and ovarian cancers: prospective studies. Adv Exp Med Biol (2008) 1.79
Dyslipidemia and inflammation: an evolutionary conserved mechanism. Clin Nutr (2005) 1.66
Total cholesterol and cancer risk in a large prospective study in Korea. J Clin Oncol (2011) 1.59
Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk. Cancer Epidemiol Biomarkers Prev (2005) 1.50
Trends in cardiovascular diseases and cancer mortality in 45 countries from five continents (1980-2010). Eur J Prev Cardiol (2013) 1.48
Statin use and risk of breast cancer: a meta-analysis of observational studies. Breast Cancer Res Treat (2012) 1.47
Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: a nested case-control study. Nutr Metab Cardiovasc Dis (2009) 1.43
Metabolic syndrome affects breast cancer risk in postmenopausal women: National Cancer Institute of Naples experience. Cancer Biol Ther (2010) 1.43
Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project. Cancer Epidemiol Biomarkers Prev (2010) 1.37
Serum lipids and breast cancer risk: a cohort study of 5,207 Danish women. Cancer Causes Control (1992) 1.35
Role of lipids, lipoproteins and vitamins in women with breast cancer. Clin Biochem (2001) 1.25
Impact of metabolic factors on subsequent cancer risk: results from a large-scale population-based cohort study in Japan. Eur J Cancer Prev (2009) 1.24
A longitudinal study of the metabolic syndrome and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev (2009) 1.22
Association between high-density lipoprotein cholesterol and breast cancer varies by menopausal status. Cancer Epidemiol Biomarkers Prev (1998) 1.19
HDL-cholesterol and incidence of breast cancer in the ARIC cohort study. Ann Epidemiol (2008) 1.19
Serum cholesterol levels in relation to the incidence of cancer: the JPHC study cohorts. Int J Cancer (2009) 1.16
Breast cancer risk in relation to serum cholesterol, serum beta-lipoprotein, height, weight, and blood pressure. Acta Oncol (1988) 1.14
Metabolic syndrome and postmenopausal breast cancer: systematic review and meta-analysis. Menopause (2013) 1.06
Cholesterol and breast cancer development. Curr Opin Pharmacol (2012) 1.05
Comparison of aerobic exercise, diet or both on lipids and lipoproteins in adults: a meta-analysis of randomized controlled trials. Clin Nutr (2011) 1.04
Risk of breast cancer in relation to blood lipids: a prospective study of 31,209 Norwegian women. Cancer Causes Control (1994) 1.03
Breast cancer and serum cholesterol. J Natl Cancer Inst (1982) 1.02
Prospective associations between serum biomarkers of lipid metabolism and overall, breast and prostate cancer risk. Eur J Epidemiol (2014) 1.01
Serum triglycerides and cancer risk in the metabolic syndrome and cancer (Me-Can) collaborative study. Cancer Causes Control (2010) 1.01
Metabolic syndrome and incidence of liver and breast cancers in Japan. Cancer Epidemiol (2011) 1.00
Interleukin-10 promoter polymorphism is associated with decreased breast cancer risk. Breast Cancer Res Treat (2005) 0.99
Iron, lipids, and risk of cancer in the Framingham Offspring cohort. Am J Epidemiol (2005) 0.98
Total serum cholesterol and cancer incidence in the Metabolic syndrome and Cancer Project (Me-Can). PLoS One (2013) 0.98
Epidemiology of dyslipidemia and economic burden on the healthcare system. Am J Manag Care (2007) 0.98
Cholesterol and breast cancer pathophysiology. Trends Endocrinol Metab (2014) 0.97
The possible role of lipid peroxidation in breast cancer risk. Free Radic Biol Med (1991) 0.94
Lipid profiles and risk of breast and ovarian cancer in the Swedish AMORIS study. Cancer Epidemiol Biomarkers Prev (2012) 0.92
Serum total cholesterol and the risk of breast cancer in postmenopausal Korean women. Cancer Causes Control (2009) 0.89
Total serum cholesterol and triglycerides and risk of breast cancer: a prospective study of 24,329 Norwegian women. Cancer Res (1990) 0.89
Components of metabolic syndrome and risk of breast cancer by prognostic features in the study of osteoporotic fractures cohort. Cancer Causes Control (2012) 0.89
The role of dietary factors in prevention and progression of breast cancer. Anticancer Res (2014) 0.87
Risk of breast cancer in relation to anthropometry, blood pressure, blood lipids and glucose metabolism: a prospective study within the Malmö Preventive Project. Eur J Cancer Prev (2001) 0.85
The role of developing breast cancer in alteration of serum lipid profile. J Res Med Sci (2012) 0.83
Cardiometabolic factors and breast cancer risk in U.S. black women. Breast Cancer Res Treat (2012) 0.82
Serum cholesterol level, use of a cholesterol-lowering drug, and breast cancer: results from the prospective E3N cohort. Eur J Cancer Prev (2010) 0.82
Cardiovascular aspects of androgens in women. Semin Reprod Endocrinol (1998) 0.79
Breast cancer incidence in ex-smokers in relation to body mass index, weight gain and blood lipid levels. Eur J Cancer Prev (2001) 0.78
Antihypertensive drug use and breast cancer risk: a meta-analysis of observational studies. Oncotarget (2017) 0.75
Antihypertensive drug use and breast cancer risk: a meta-analysis of observational studies. Oncotarget (2017) 0.75